OTC Markets OTCPK - Delayed Quote USD

Genus plc (GENSF)

Compare
20.51 0.00 (0.00%)
At close: November 21 at 3:00 PM EST
Loading Chart for GENSF
DELL
  • Previous Close 21.80
  • Open 22.20
  • Bid 20.68 x 40000
  • Ask 22.26 x 38800
  • Day's Range 22.20 - 22.20
  • 52 Week Range 20.51 - 28.34
  • Volume 300
  • Avg. Volume 92
  • Market Cap (intraday) 1.406B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 136.73
  • EPS (TTM) 0.15
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 0.41 (2.00%)
  • Ex-Dividend Date Nov 7, 2024
  • 1y Target Est --

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

www.genusplc.com

3,500

Full Time Employees

June 30

Fiscal Year Ends

Recent News: GENSF

View More

Performance Overview: GENSF

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GENSF
26.71%
FTSE 100
6.84%

1-Year Return

GENSF
26.71%
FTSE 100
10.43%

3-Year Return

GENSF
71.74%
FTSE 100
14.38%

5-Year Return

GENSF
45.16%
FTSE 100
14.14%

Compare To: GENSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GENSF

View More

Valuation Measures

Annual
As of 11/21/2024
  • Market Cap

    1.37B

  • Enterprise Value

    1.68B

  • Trailing P/E

    136.21

  • Forward P/E

    23.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.60

  • Price/Book (mrq)

    1.96

  • Enterprise Value/Revenue

    1.99

  • Enterprise Value/EBITDA

    18.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.18%

  • Return on Assets (ttm)

    3.31%

  • Return on Equity (ttm)

    0.43%

  • Revenue (ttm)

    668.8M

  • Net Income Avi to Common (ttm)

    7.9M

  • Diluted EPS (ttm)

    0.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    42.5M

  • Total Debt/Equity (mrq)

    53.54%

  • Levered Free Cash Flow (ttm)

    42.9M

Research Analysis: GENSF

View More

Company Insights: GENSF

Research Reports: GENSF

View More

People Also Watch